drive
  • home
  • About us
  • Services
  • Infrastructure
  • Franchises
  • Investors
  • Contact
Financials Investor Info Corporate Governance Scheme of Amalgamation Feedback
Annual Reports Annual Returns Quarterly Reports Postal Ballot Subsidiary Financials


  • Annual Report 2023-24


  • Annual Return FY 2023-24


  • 4th Quarter (January – March, 2025)
  • 3rd Quarter (October – December, 2024)
  • 2nd Quarter (July – September, 2024)
  • 1st Quarter (April – June, 2024)

  • Results of Postal Ballot
  • Postal Ballot Notice-2021

  • Medinova Millennium MRI Services LLP FY 2023-24
  • MRI LLP Financials Signed 2022-23
  • Medinova Millennium MRI Services LLP FY 2021-22
Shareholding BDM Notice AGM Notice Media Advt Contact Registrar & Transfer Agents Handling & Redressal E-Voting


  • As on 31.03.2025
  • As on 31.12.2024
  • As on 30.09.2024
  • As on 30.06.2024


Sub: Board Meeting Intimation - Regulation 29 of Listing Regulations
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, May 3, 2025, inter alia, to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2025.

 

Sub: Board Meeting Intimation - Regulation 29 of Listing Regulations
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, January 30, 2025, inter alia, to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the third quarter and nine months ended December 31, 2024.

 

Sub: Board Meeting Intimation- Regulation 29 of Listing Regulations
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, July 30, 2024, inter alia, to consider and approve the audited financial results (standalone and consolidated) of the Company for the first quarter ended June 30, 2024.

 

 Sub: Board Meeting Intimation- Regulation 29 of Listing Regulations

Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, April 26, 2024, inter alia, to consider and approve the audited financial results (standalone and consolidated) of the Company for the fourth quarter and financial year ended March 31, 2024.

  • AGM transcript 2024
  • AGM Notice 2023-24
  • AGM Notice 2022-23
  • 29th AGM Notice
  • 28th AGM Notice
  • 27th AGM Notice
  • 26th AGM Notice
  • 25th AGM Notice
  • 24th AGM Notice
  • Quarterly and Annual Results 31.03.2024
  • Quarterly Results 31.12.2023
  • Quarterly Results 30.09.2023 (Q2)
  • Quarterly Results 30.06.2023 (Q1)
  • MDSl Newspaper Advt - 26-08-2023
  • MDSL - Newspaper Advt - AGM 2023
  • Quarterly Results 31.03.2023 (Q4)
  • Quarterly Results 31.12.2022 (Q3)
  • Quarterly Results 30.09.2022 (Q2)
  • Quarterly Results 30.06.2022 (Q1)
  • 29TH AGM NOTICE (2021-22)
  • Quarterly & Yearly Results - 31.03.2022
  • Quarterly Results 31.12.2021 (Q.3)
  • Quarterly Results 30.09.2021 (Q.2)
  • Quarterly Results 30.06.2021 (Q.1)
  • 28TH AGM NOTICE (2020-21)
  • Notice of Postal Ballot Dispatch
  • Information regarding Postal Ballot/E-Voting
  • Quarterly & Yearly Results 31.03.2021 (Q.4)
  • Board Meeting Notice - English & Telugu - 4th Quarter Dt. 16.04.2021
  • Quarterly Results 31.12.2020 (Q.3)
  • Board Meeting Notice - English & Telugu - 3rd Quarter Dt. 02.02.2021
  • Quarterly Results 30.09.2020 (Q.2)
  • Board Meeting Notice - English & Telugu - 2nd Quarter Dt. 05.11.2020
  • 27TH AGM NOTICE (2019-20)
  • Quarterly Results 30.06.2020 (Q.1)
  • Board Meeting Notice - English & Telugu - 1st Quarter Dt. 05.08.2020
  • Quarterly Results 31.12.2019 (Q3)
  • Board Meeting Notice - English & Telugu - 3rd Quarter Dt.25.01.2020
  • Quarterly Results 30.09.2019 (Q2)
  • Board Meeting Notice - Telugu - 2nd Quarter Dt.31.10.2019
  • Board Meeting Notice - English - 2nd Quarter Dt.31.10.2019
  • 26th AGM Notice (2018-19)
  • Quarterly Results 30.06.2019 (Q1)
  • Board Meeting Notice - English - 1st Quarter Dt.02.08.2019
  • Board Meeting Notice - Telugu - 1st Quarter Dt.02.08.2019
  • Quarterly Results 31.03.2019
  • Quarterly Results 31.12.2018
  • Board Meeting Notice - Telugu - 3rd Quarter (03.02.2019)
  • Board Meeting Notice -English - 3rd Quarter (03.02.2019)
  • Quarterly Results 30.09.2018
  • Board Meeting Notice 03.11.2018 (english)
  • Board Meeting Notice 03.11.2018 (telugu)
  • 25th AGM Notice (2017-18)
  • Board Meeting Notice 22.05.2018
  • Quarterly Results 31.03.2018 (english)
  • Quarterly Results 31.03.2018 (telugu)
  • Print Media Ad for 2016-17

Contact Information & Address of the designated Official :-


Company Secretary,
Medinova Diagnostic Services Limited,
H. No. 7-1-58, Unit No. 1/Flat No.301,
3rd Floor Amrutha Business Complex,
Ameerpet, Hyderabad-500016, Telangana, India
Ph: 040-42604250
Email: medicorp@medinovaindia.com

M/s. XL Softech Systems Limited
#3, Sagar Society,
Road No.2 Banjara Hills,
HYDERABAD – 500 034
Ph: 040-23545913 / 14 / 15, Fax: 040-23553214

 

Information to be provided to RTA, if holding shares in physical form

The Securities and Exchange Board of India (‘SEBI’) vide its circular dated 03rdNovember 2021 has made it mandatory for the shareholders holding securities in physical form to furnish PAN, KYC details and Nomination to the Registrar and Transfer Agent (‘RTA’) of the Company. In case of failure to provide required documents and details as per the aforesaid SEBI circular, all folios of such shareholders shall be frozen on or after 01stApril 2023 by the RTA. Click here for SEBI circular

In view of the above, shareholders of the Company holding securities in physical form shall provide following documents/details to RTA:

  • PAN
  • Nomination (for all eligible folios) in Form No. SH-13 or submit declaration to ‘Opt-out’ in Form ISR-3
    Note: Any cancellation or change in nomination shall be provided in Form No.
  • Contact details including Postal address with PIN code, Mobile Number, E-mail address
  • Bank Account details including Bank name and branch, Bank account number, IFS code
  • Specimen signature

The above documents/details are to be provided to Company’s RTA i.e. Xl Softech Systems Limited, 3, Sagar Society, Road No.2, Banjara Hills,  Hyderabad 500 034, Telangana, India or email at xlfield@gmail.com along with Name and folio numbers.

The shareholders can download the forms mentioned in SEBI circular as given below:

Sr. No.

Form

Purpose

Download Form

1

Form ISR-1

Request for Registering PAN, KYC details OR Changes/updations there of (only for securities held in physical

ISR-1

2

Form ISR-2

Confirmation of Signature of securities holder by Banker

ISR-2

3

Form ISR-3

Declaration for Opting-out of Nomination by holders of physical securities in Listed Companies

ISR-3

4

Form SH-13

Nomination Form

SH-13

5

Form SH-14

Cancellation OR Variation of Nomination

SH-14


M/s. XL Softech Systems Limited
#3, Sagar Society,
Road No.2 Banjara Hills,
HYDERABAD – 500 034
Ph: 040-23545913 / 14 / 15, Fax: 040-23553214

 

Online Dispute Resolution Mechanism

 

 

Medinova - Voting Results and Report


Voting results of 30th AGM - 2023


30th AGM Proceedings


Voting results of 29th AGM - 2022


Voting results of 28th AGM - 2021


Voting results of 27th AGM - 2020


Voting results of 26th AGM - 2019


Voting results of 25th AGM - 2018


Voting results of 24th AGM - 2017


POSTAL BALLOT :

Notice - November, 2016

Results - January, 2017


Voting results of 23rd AGM - 2016.


e-Voting and Physical Ballot Results Report by Scrutinizer – 2015

AGM Report as per Clause 35A of the Listing Agreement.

Board Directors Company Philosophy Policy Documents Stock Exchange Compliances Stock Exchange Communication

Dr. Sura Surendranath Reddy – Chairman / Non-Executive Director:

 
Dr. Sura Surendranath Reddy (DIN 0108599 )  did his M.D. (Radiology) from Osmania Medical College, Hyderabad. He is a Medical Doctor by profession and is a founder Chairman of M/s. Vijaya Diagnostic Centre Private Limited (VDCPL). Dr. S Surendranath Reddy has established Diagnostic Centre as the centre of excellence for diagnostic Medicare, offering the most state of the art technologies and ensuring reliable and accurate services, in a professionally managed environment. He has vast experience in providing comprehensive range of diagnostic services spanning Radiology & Imaging, Nuclear Medicine, Conventional & Speciality Lab Services and Diagnostic Cardiology.Over the past 29 years, his passion for quality and commitment to delivering the latest in technology to customers, have translated into a number of First initiatives in Diagnostic Services by him. VDCPL today has over 33 branches and caters to over 6000 patients every day.
 
 
Mr. Sunil Chandra Kondapally – Managing Director:
 
Mr. Sunil Chandra Kondapally (DIN 01409332) is a B.Sc (Electrical Engineering) from Florida State University, USA.  He is also Director of M/s. Vijaya Diagnostic Centre Private Limited and M/s. QPS Bioserve Clinical Services Private Limited. He has vast experience in medical field. Engineer by Qualification he has been closely involved in the operations, strategy administration at Vijaya Diagnostic Centre (Pvt.) Limited since 1998.Also founded a well recognized Contract researchpharmaceuticals company in 2004, which became a joint venture with QPS LLC, USA in 2011.

 

Mr. Ravi Kumar Reddy Kanamatareddy : Non- Executive Independent Director:
 
Mr. Ravi Kumar Reddy Kanamatareddy (DIN: 10663314) holds degree in Bachelor of Architecture from Jawaharlal Nehru Technological University (JNTU) and has a Post Graduate Diploma in from CEPT University. He has received several recognitions from well-known institutions like FIIA and FITP. He is retired after working 15 years for IBM India Pvt. Ltd. as Systems Architect. He has several publications in IIA Journal, ITPI Journal and various Conference publications and IEEE.
 
 
Mr. P. Kamalakar Rao - Non-Executive Director:
 
Mr. P. Kamalakar Rao (DIN 03057676) is a senior fellow member of The Institute of Chartered Accountants of India. He is the managing partner of AMALAKARA RAO & CO. His other interests include sports, script writing for television serials, movies and documentaries. He has also produced television serials and movies in Hindi and English. His movie in English won many international awards.
 
 
Mrs. B. Vishnu Priya Reddy- Non-Executive Director:

Mrs. B. Vishnu Priya Reddy is a graduate in Computer Science. She has nearly 10+ years of experience of working in various positions in diagnostic service sector, in hospitality industry and uplifting children along with women. With proven ability to constantly challenge and improve existing processes and systems, she has been participating and rendering voluntary services to many social organizations.
 
In addition to this, she regularly does community services towards encouragement of economically weaker women. Mrs. B. Vishnu Priya Reddy is also a director in Summit Nutraceuticals Private Limited.

 


 The  Company  believes in fair business and  Corporate  Practices while  dealing with all the shareholders, customers  and  others.  The Company believes in discharging its statutory obligations and duties to its best ability.


Directorships & full-time positions in body corpor :-

  • Download

MDSL - MOA & AOA :-

  • Download

Code of Conduct & Ethics :-

  • Download

Policy on Related Party Transactions :-

  • Download

Terms & Conditions for appointment of Independent Directors :-

  • Download

Code of Conduct for Independent Directors :-

  • Download

Code of Practices and Procedures for Fair Disclosure of Unpublished
Price Sensitive Information with effect from 1st April 2019 :-

  • Download

Whistle Blower Policy :-

  • Download

Familiarisation Program for Independent Directors :-

  • Download

POLICY FOR PRESERVATION OF DOCUMENTS and ARCHIVAL OF DOCUMENTS :-

  • Download

Policy on criteria for determining materiality of events :-

  • Download

Performance Evaluation, Nomination & Remuneration Policy :-

  • Download

Criteria for Payment to Non executive Directors :-

  • Download

Committees of the Board :-

  • Download


  • Quarter ended 31.03.2017
  • Quarter ended 31.12.2016
  • Quarter ended 30.09.2016
  • Quarter ended 30.06.2016

Compliance Report on Corporate Governance :-

  • Quarter ended 29.03.2023
  • Quarter ended 31.12.2022
  • Quarter ended 30.09.2022
  • Quarter ended 30.06.2022
  • Quarter ended 31.03.2022
  • Quarter ended 31.12.2021
  • Quarter ended 30.09.2021
  • Quarter ended 30.06.2021
  • Quarter ended 31.03.2021
  • Quarter ended 31.12.2020
  • Quarter ended 30.09.2020
  • Quarter ended 30.06.2020
  • Quarter ended 31.03.2020
  • Quarter ended 31.12.2019
  • Quarter ended 30.09.2019
  • Quarter ended 30.06.2019
  • Quarter ended 31.03.2019
  • Quarter ended 31.12.2018
  • Quarter ended 30.09.2018
  • Quarter ended 30.06.2018

Reconciliation of Share Capital Audit Reports :-

  • Quarter ended 31.12.2021
  • Quarter ended 30.09.2021
  • Quarter ended 30.06.2021
  • Quarter ended 31.03.2021
  • Quarter ended 31.12.2020
  • Quarter ended 30.09.2020
  • Quarter ended 30.06.2020
  • Quarter ended 31.03.2020
  • Quarter ended 31.12.2019
  • Quarter ended 30.09.2019
  • Quarter ended 30.06.2019
  • Quarter ended 31.03.2019
  • Quarter ended 31.12.2018
  • Quarter ended 30.09.2018
  • Quarter ended 30.06.2018

Certificate from PCS under Regulation 40(9) :-

  • HY ended 31.03.2021
  • HY ended 30.09.2020
  • HY ended 31.03.2020
  • HY ended 30.09.2019
  • HY ended 31.03.2019
  • HY ended 30.09.2018

Stock Exchange Communication :-

  • Newspaper Publication of Financial Results – Q4 FY 2025
  • Closure of Trading Window – Q4 – March 26, 2025
  • MDSL - Reg 30 Intimation - 06-02-2025
  • Change in Management – 30.01.2025
  • Resignation of Internal Auditor
  • Closure of Trading Window – Q3 – December 24, 2024
  • Resignation of CFO
  • MDSL - Outcome of Board Meeting - 29 October, 2024
  • Summary of 31st AGM Proceedings
  • Publication of Notice of 31st AGM
  • Publication of Pre-despatch AGM Intimation
  • BSE Complaint Report
  • Newspaper Publication of Q1 Financial Results FY 2024-25
  • MDSL - Outcome of Board Meeting - 30 July, 2024
  • Application under Regulation 37
  • Scheme of Amalgamation
  • Joint Valuation Report
  • Fairness Opinion
  • Audit Committee Report
  • Certificate of Statutory Auditor
  • Compliance Report
  • Independent Directors Report
  • Confirmation
  • Undertaking for NOC
  • Q1- Closure of Trading Window FY 2024-25
  • MDSL - Outcome of Board Meeting - 26 June 2024
  • MDSL - Press Release on Amalgamation
  • Reg. 30 Appointment of Independent Director
  • Reg 30 - Resignation of Internal Auditor
  • Retirement of Independent Director
  • Q4 – Closure of Trading Window
  • Appointment of CFO - 31st Jan 2024
  • Q3 - Closure of Trading Window
  • Authorisation under Reg 30(5) - 02-11-2023
  • Q2 - Closure of Trading Window
  • Appt. of Internal Auditors & Secretarial Auditors
  • Q1 - Closure of Trading Window
  • Authorisation As Per Regulation 30(5) of SEBI (LODR) Regulations, 2015
  • Resignation of Company Secretary and Compliance Officer
  • Appointment of Compliance Officer
  • Q3-Closure of Trading Window
  • Change in Registered Office Address
  • Appointment of Company Secretary
  • Appointment of Company Secretary and Compliance Officer
  • Disclosure-Acquisition
  • Resignation of Company Secretary and Compliance Officer
  • Appointment of Chief Financial Officer
  • AUDITOR RESIGN-ST.EX 23-04-2021
  • Resignation of CFO Mr. Hrusikesh Behera
  • Resignation of Director-Dr. Balamba Puranam

Check out below link

  • MDSL - Equity Shareholders
  • MDSL Scrutinizer Report and V.R.
  • MDSL Proceedings Equity Shareholders
  • Notice of Equity Shareholders Meeting
  • MDSL Newspaper Ad. Notice
  • BSE OBSERVATION LETTER
  • Application under Regulation 37
  • Audit Committee Report
  • BSE Complaint Report
  • Certificate of Statutory Auditor
  • Compliance Report
  • Confirmation
  • Fairness Opinion
  • Independent Directors Report
  • Joint Valuation Report
  • Scheme of Amalgamation
  • Undertaking for NOC
  • For any Information and Queries contact:

     

    • medicorp@medinovaindia.com

ISO 9002 Certified

© Copyright Medinova Diagnostic Services Ltd. - All rights reserved.

Powered By :